BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 33031621)

  • 1. Dermatologic adverse reactions to proton-pump inhibitors: A synthetized review.
    Salloum A; Nasr D; Maalouf D
    J Cosmet Dermatol; 2021 Apr; 20(4):1073-1079. PubMed ID: 33031621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management.
    Otani IM; Banerji A
    Curr Allergy Asthma Rep; 2016 Mar; 16(3):17. PubMed ID: 26810177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management.
    Kepil Özdemir S; Bavbek S
    Allergy Asthma Proc; 2020 Mar; 41(2):e37-e44. PubMed ID: 32122452
    [No Abstract]   [Full Text] [Related]  

  • 4. Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity.
    Kepil Özdemir S; Yılmaz I; Aydin Ö; Büyüköztürk S; Gelincik A; Demirtürk M; Erdoğdu D; Cömert S; Erdoğan T; Karakaya G; Kalyoncu AF; Oner Erkekol F; Dursun AB; Misirligil Z; Bavbek S
    Allergy; 2013 Aug; 68(8):1008-14. PubMed ID: 23895584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Hypersensitivity Reactions to Proton Pump Inhibitors: A Retrospective Experience.
    Kepil Özdemir S; Öner Erkekol F; Ünal D; Büyüköztürk S; Gelincik A; Dursun AB; Karakaya G; Bavbek S
    Int Arch Allergy Immunol; 2016; 171(1):54-60. PubMed ID: 27838693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study.
    Lin CY; Wang CW; Hui CR; Chang YC; Yang CH; Cheng CY; Chen WW; Ke WM; Chung WH
    Allergy; 2018 Jan; 73(1):221-229. PubMed ID: 28658503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate-Type Hypersensitivity Cross-Reactions to Proton Pump Inhibitors: A Descriptive Study of Data from the French National Pharmacovigilance Database.
    Tourillon C; Mahe J; Baron A; Lambert A; Yélehé-Okouma M; Veyrac G; Jolliet P
    Int Arch Allergy Immunol; 2019; 178(2):159-166. PubMed ID: 30485850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cross-reactivity between proton pump inhibitors.
    Sobrevia Elfau MT; Garcés Sotillos M; Ferrer Clavería L; Segura Arazuri N; Monzón Ballarin S; Colás Sanz C
    J Investig Allergol Clin Immunol; 2010; 20(2):157-61. PubMed ID: 20461971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of hypersensitivity to proton pump inhibitors.
    Bose S; Guyer A; Long A; Banerji A
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):452-7. PubMed ID: 24267357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypersensitivity to proton pump inhibitors].
    Bergmann M; Guignard B; Ribi C
    Rev Med Suisse; 2012 Apr; 8(337):830-5. PubMed ID: 22594006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions to proton pump inhibitors.
    Chang YS
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):348-53. PubMed ID: 22744268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous reactions to proton pump inhibitors: a case-control study.
    Chularojanamontri L; Jiamton S; Manapajon A; Suvanasuthi S; Kulthanan K; Dhana N; Jongjarearnprasert K
    J Drugs Dermatol; 2012 Oct; 11(10):e43-7. PubMed ID: 23134998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions to proton pump inhibitors in childhood.
    Mori F; Franceschini F; Saretta F; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Liotti L; Paglialunga C; Caffarelli C
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():29-32. PubMed ID: 33236429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esomeprazole: a safe alternative to lansoprazole allergy?
    Kara M; Tanoglu A; Kutlu A; Sirkeci O; Kekilli M
    Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):296-7. PubMed ID: 24659167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis due to proton pump inhibitors: current understanding and important clinical considerations.
    Benito-Garcia F; Chambel M; Morais-Almeida M
    Expert Rev Clin Immunol; 2018 Aug; 14(8):653-656. PubMed ID: 30058396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper.
    Bavbek S; Kepil Özdemir S; Bonadonna P; Atanaskovic-Markovic M; Barbaud A; Brockow K; Laguna Martinez J; Nakonechna A; Pagani M; Arcolacı A; Lombardo C; Torres MJ
    Allergy; 2024 Mar; 79(3):552-564. PubMed ID: 38013608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study.
    Ramírez E; Cabañas R; Laserna LS; Fiandor A; Tong H; Prior N; Calderón O; Medrano N; Bobolea I; Frías J; Quirce S
    Clin Exp Allergy; 2013 Mar; 43(3):344-52. PubMed ID: 23414543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immediate type reactions to proton pump inhibitors using pantoprazole and omeprazole as examples].
    Dohr J; Hunzelmann N; Brown A
    Hautarzt; 2018 Feb; 69(2):162-164. PubMed ID: 29085952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z; Guo A; Wu C; Wang C
    J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPI adverse drugs reactions: a retrospective study.
    Casciaro M; Navarra M; Inferrera G; Liotta M; Gangemi S; Minciullo PL
    Clin Mol Allergy; 2019; 17():1. PubMed ID: 30675130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.